Therapeutic Areas

/ Patients / Therapeutic Areas

We are currently studying itolizumab in a number of clinical trials in diseases where immuno-inflammation plays a role, including graft-versus-host disease, uncontrolled moderate to severe asthma, and SLE / lupus nephritis. By restoring the balance of T cells in the immune system, we hope to restore the balance of life for patients in need.